Naltrexone–bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports

AIMS: To compare the benefits and harms of naltrexone–bupropion using evidence from clinical study reports. METHODS: We searched Food and Drug Administration and European Medicines Agency websites, PubMed, and Clinicaltrials.gov (May 2016) to identify pivotal trials; we then sent a freedom of inform...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Br J Clin Pharmacol
Huvudupphovsmän: Onakpoya, Igho J., Lee, Joseph J., Mahtani, Kamal R., Aronson, Jeffrey K., Heneghan, Carl J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2020
Ämnen:
Systematic Review and Meta‐analysis
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7098870/
https://ncbi.nlm.nih.gov/pubmed/31918448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14210
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk